Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Study: Boosts in R&D spending drive biotech innovation

Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in R&D, according to the sixth annual study from BDO USA. The 2017 BDO Biotech Briefing, which examines the most recent 10-K SEC filings of publicly traded companies included in the NASDAQ Biotechnology Index, found that […]

The post Study: Boosts in R&D spending drive biotech innovation appeared first on CenterWatch News Online.

Powered by WPeMatico

News

Experimental HIV vaccine regimen is well-tolerated, elicits immune responses

Results from an early-stage clinical trial called APPROACH show that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against HIV in healthy adults. Powered by WPeMatico

more >

HIV: Could new injection work as effectively as daily drugs?

A new, long-acting antiretroviral injection is as effective in managing HIV as daily-dosage oral drugs, a recent clinical trial suggests. Powered by WPeMatico

more >

Christiana Care’s Gene Editing Institute, NovellusDx partner

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System’s Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx. The Gene Editing Institute has licensed its innovative gene editing technology to Jerusalem-based NovellusDx to improve the […]

more >

Science Exchange R&D outsourcing platform to receive privacy certification

Science Exchange is the first and only R&D outsourcing platform to receive EU-U.S. Privacy Shield Framework certification from the U.S. Department of Commerce. This certification demonstrates the company’s commitment to the protection and privacy of sensitive data shared by its customers and scientific service providers on the Science Exchange platform. Designed by the U.S. Department […]

more >

Adimab announces platform transfer with Lilly

Adimab, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas. This technology transfer expands an ongoing collaboration between the two companies that […]

more >

Takeda, Schrödinger form research collaboration

Takeda Pharmaceutical and Schrödinger, a privately held company dedicated to revolutionizing drug discovery through advanced computational methods, announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic areas of interest. The unique collaboration will combine Schrödinger’s in silico platform-driven drug discovery capabilities with Takeda’s deep therapeutic area knowledge and expertise […]

more >